Halozyme Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 1.5M | 1.16 |
| 2025-06-30 | $2.7M | 2.7M | 1.00 |
| 2025-03-31 | $9.0M | 8.5M | 1.06 |
| 2024-12-31 | $6.2M | 6.5M | 0.95 |
| 2024-09-30 | $4.7M | 4.7M | 1.00 |
| 2024-06-30 | $14M | 15M | 0.95 |
| 2024-03-31 | $14M | 15M | 0.89 |
| 2023-12-31 | $13M | 15M | 0.86 |
| 2023-09-30 | $12M | 14M | 0.85 |
| 2023-06-30 | $8.4M | 10M | 0.83 |
| 2022-12-31 | $1.9M | 2.0M | 0.97 |
| 2022-09-30 | $834k | 978k | 0.85 |
| 2022-06-30 | $737k | 828k | 0.89 |
| 2022-03-31 | $1.6M | 1.8M | 0.88 |